These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38602300)

  • 1. Serum apelin as a potential biomarker for infantile hemangiomas.
    Chen Q; Zhang Y; Ni S; Yang L; Li J; Yuan X; Chen M; Liu J; Luo X; Xie Y; Wang H
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30989. PubMed ID: 38602300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of propranolol gel on plasma VEGF, bFGF and MMP-9 in proliferating infantile hemangiomas of superficial type].
    Yujuan T; Shaoquan C; Zaizhong Z; Shuming C; Guoliang H; Lie W
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jul; 31(4):268-73. PubMed ID: 26665926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.
    Aydin Köker S; Kömüroğlu AU; Köksoy AY; Şiraz ÜG; Tekin E; Köker A
    Arch Pediatr; 2021 May; 28(4):296-300. PubMed ID: 33715934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas.
    Tang YJ; Zhang ZZ; Chen SQ; Chen SM; Li CJ; Chen JW; Yuan B; Xia Y; Wang L
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):759-762. PubMed ID: 26489635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of serum vascular endothelial growth factor in infantile hemangiomas.
    Paria S; Mendiratta V; Chander R; Jain A; Mittal S
    Indian J Dermatol Venereol Leprol; 2019; 85(1):65-68. PubMed ID: 29469063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Infantile Hemangioma Versus Vascular Malformations.
    El-Raggal NM; El-Farrash RA; Saad AA; Attia EAS; Saafan HA; Shaaban IS
    Clin Appl Thromb Hemost; 2018 May; 24(4):663-668. PubMed ID: 28595487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
    Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
    Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
    Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
    Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apelin Receptor Can Act as a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma.
    Chen Q; Ying H; Yu Z; Chang L; Chen Z; Chen J; Chang SJ; Qiu Y; Lin X
    J Invest Dermatol; 2023 Apr; 143(4):566-577.e12. PubMed ID: 36243122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
    Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
    Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.
    Lorusso B; Nogara A; Fioretzaki R; Corradini E; Bove R; Roti G; Gherli A; Montanaro A; Monica G; Cavazzini F; Bonomini S; Graiani G; Silini EM; Gnetti L; Pilato FP; Cerasoli G; Quaini F; Lagrasta CAM
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
    Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
    J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Infantile Hemangioma a Neuroendocrine Tumor?
    Kaulanjan-Checkmodine P; Oucherif S; Prey S; Gontier E; Lacomme S; Loot M; Miljkovic-Licina M; Cario M; Léauté-Labrèze C; Taieb A; Moisan F; Rezvani HR
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.
    Zhang L; Mai HM; Zheng J; Zheng JW; Wang YA; Qin ZP; Li KL
    Int J Clin Exp Pathol; 2014; 7(1):48-55. PubMed ID: 24427325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma.
    Makkeyah SM; Elseedawy ME; Abdel-Kader HM; Mokhtar GM; Ragab IA
    Pediatr Hematol Oncol; 2022 Apr; 39(3):215-224. PubMed ID: 34477031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol].
    Zhao ZF; Lü RR; Huo R; Fu HB; Xu GQ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Sep; 27(5):359-61. PubMed ID: 22259987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
    Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
    Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.